Darko Skegro, PhD

Director and Site Head, Biotherapeutic Engineering and Conjugation at Novartis

Speaker

Dr. Darko Skegro is Director and Site Head of Biotherapeutic Engineering and Conjugation at Novartis` Biologics Research Center in Basel. Since joining Novartis in 2015, Dr. Skegro has led protein engineering and conjugation teams, responsible for strategies bringing novel concepts to drug development. Numerous drugs Dr. Skegro`s teams engineered entered clinical phases. Prior to joining Novartis, Dr. Skegro served as Head of Bispecific Antibodies at Glenmark. Dr. Skegro earned his PhD from the Research Center Jülich in Germany and completed postdoctoral training in structural biology at the Biozentrum, Basel. He is inventor and co-inventor of more than 25 patents and applications in the field of therapeutic proteins, including multispecific antibodies.